CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Ordinary Shares	Additional Paid-In Capital	Accumulated Other Comprehensive Gain (Loss)	Accumulated Deficit	Total
Balances at Dec. 31, 2022	$ 1	$ 1,295,725	$ (15)	$ (853,911)	$ 441,800
Balances (in shares) at Dec. 31, 2022	65,227
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(166,787)			(166,787)
Repurchase of ordinary shares, net of transaction costs (in shares)	(15,619)
Proceeds from ESPP purchases		445			445
Proceeds from ESPP purchases (in shares)	63
Employee share-based compensation expense		19,547			19,547
Issuance of restricted shares (in shares)	1,337
Repurchase of shares to satisfy tax withholding		(1,982)			(1,982)
Repurchase of shares to satisfy tax withholding (in shares)	(189)
Net unrealized gain (loss) on marketable securities			(210)		(210)
Net Income (Loss)				(46,683)	(46,683)
Balances at Sep. 30, 2023	$ 1	1,146,948	(225)	(900,594)	246,130
Balances (in shares) at Sep. 30, 2023	50,819
Balances at Jun. 30, 2023	$ 1	1,172,090	(286)	(891,644)	280,161
Balances (in shares) at Jun. 30, 2023	53,694
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(30,891)			(30,891)
Repurchase of ordinary shares, net of transaction costs (in shares)	(3,178)
Proceeds from ESPP purchases		(1)			(1)
Employee share-based compensation expense		6,262			6,262
Issuance of restricted shares (in shares)	356
Repurchase of shares to satisfy tax withholding		(512)			(512)
Repurchase of shares to satisfy tax withholding (in shares)	(53)
Net unrealized gain (loss) on marketable securities			61		61
Net Income (Loss)				(8,950)	(8,950)
Balances at Sep. 30, 2023	$ 1	1,146,948	(225)	(900,594)	246,130
Balances (in shares) at Sep. 30, 2023	50,819
Balances at Dec. 31, 2023		1,122,164	(65)	(909,104)	$ 212,995
Balances (in shares) at Dec. 31, 2023	48,091				48,091
Increase (Decrease) in Stockholders' Equity
Repurchase of ordinary shares, net of transaction costs		(445)			$ (445)
Repurchase of ordinary shares, net of transaction costs (in shares)	(38)
Proceeds from the sale of ordinary shares		69			69
Proceeds from the sale of ordinary shares (in shares)	8
Proceeds from ESPP purchases		375			375
Proceeds from ESPP purchases (in shares)	45
Employee share-based compensation expense		15,567			15,567
Issuance of restricted shares (in shares)	1,310
Repurchase of shares to satisfy tax withholding		(2,131)			(2,131)
Repurchase of shares to satisfy tax withholding (in shares)	(242)
Net unrealized gain (loss) on marketable securities			115		115
Net Income (Loss)				(40,891)	(40,891)
Balances at Sep. 30, 2024		1,135,599	50	(949,995)	$ 185,654
Balances (in shares) at Sep. 30, 2024	49,174				49,174
Balances at Jun. 30, 2024		1,131,008	(22)	(937,297)	$ 193,689
Balances (in shares) at Jun. 30, 2024	48,922
Increase (Decrease) in Stockholders' Equity
Proceeds from the sale of ordinary shares		25			25
Proceeds from the sale of ordinary shares (in shares)	3
Employee share-based compensation expense		4,963			4,963
Issuance of restricted shares (in shares)	297
Repurchase of shares to satisfy tax withholding		(397)			(397)
Repurchase of shares to satisfy tax withholding (in shares)	(48)
Net unrealized gain (loss) on marketable securities			72		72
Net Income (Loss)				(12,698)	(12,698)
Balances at Sep. 30, 2024		$ 1,135,599	$ 50	$ (949,995)	$ 185,654
Balances (in shares) at Sep. 30, 2024	49,174				49,174